 Bruce McCollister
Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella typhimurium | 5 | 2016 | 164 | 1.150 |
Why?
| | Anti-Bacterial Agents | 8 | 2023 | 1477 | 0.840 |
Why?
| | Salmonella Infections | 3 | 2016 | 50 | 0.610 |
Why?
| | Nitric Oxide | 5 | 2011 | 823 | 0.600 |
Why?
| | Ceftriaxone | 1 | 2016 | 18 | 0.550 |
Why?
| | Bacteremia | 2 | 2016 | 160 | 0.550 |
Why?
| | beta-Lactamases | 1 | 2016 | 25 | 0.550 |
Why?
| | Macrophages | 3 | 2007 | 1261 | 0.520 |
Why?
| | Escherichia coli Proteins | 1 | 2016 | 162 | 0.490 |
Why?
| | Bacterial Proteins | 6 | 2010 | 736 | 0.430 |
Why?
| | Aminoglycosides | 1 | 2011 | 13 | 0.370 |
Why?
| | Biological Transport | 1 | 2011 | 373 | 0.340 |
Why?
| | Salmonella enterica | 2 | 2007 | 49 | 0.310 |
Why?
| | Interferon-gamma | 3 | 2008 | 719 | 0.300 |
Why?
| | Nitrogen Oxides | 1 | 2007 | 47 | 0.290 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2007 | 21 | 0.290 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 191 | 0.280 |
Why?
| | Microbial Viability | 1 | 2007 | 79 | 0.280 |
Why?
| | Meningitis, Cryptococcal | 2 | 2018 | 28 | 0.280 |
Why?
| | Macrophage Activation | 1 | 2007 | 164 | 0.270 |
Why?
| | Abscess | 3 | 2015 | 72 | 0.260 |
Why?
| | Membrane Proteins | 3 | 2007 | 1018 | 0.260 |
Why?
| | Phagosomes | 1 | 2005 | 38 | 0.250 |
Why?
| | Skin Diseases, Bacterial | 2 | 2016 | 22 | 0.250 |
Why?
| | Skin Diseases | 2 | 2015 | 122 | 0.220 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2005 | 285 | 0.210 |
Why?
| | Pneumonia, Bacterial | 1 | 2023 | 106 | 0.210 |
Why?
| | Treatment Failure | 2 | 2016 | 331 | 0.160 |
Why?
| | Staphylococcal Infections | 2 | 2015 | 336 | 0.150 |
Why?
| | Hospitalization | 3 | 2016 | 1749 | 0.150 |
Why?
| | Cryptococcosis | 1 | 2018 | 23 | 0.150 |
Why?
| | Sepsis | 1 | 2023 | 509 | 0.140 |
Why?
| | Staphylococcus aureus | 2 | 2011 | 385 | 0.140 |
Why?
| | Prophages | 1 | 2016 | 4 | 0.140 |
Why?
| | Ciprofloxacin | 1 | 2016 | 23 | 0.140 |
Why?
| | Gastrointestinal Microbiome | 1 | 2023 | 501 | 0.140 |
Why?
| | Cryptococcus | 1 | 2016 | 8 | 0.140 |
Why?
| | Antigens, Fungal | 1 | 2016 | 24 | 0.130 |
Why?
| | Pelvic Infection | 1 | 2016 | 4 | 0.130 |
Why?
| | Tissue Adhesives | 1 | 2016 | 16 | 0.130 |
Why?
| | Escherichia coli | 2 | 2016 | 720 | 0.130 |
Why?
| | Gelatin | 1 | 2016 | 36 | 0.130 |
Why?
| | Genome, Bacterial | 1 | 2016 | 106 | 0.130 |
Why?
| | Air Filters | 1 | 2015 | 2 | 0.130 |
Why?
| | Plasmids | 1 | 2016 | 343 | 0.130 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 300 | 0.130 |
Why?
| | Polyurethanes | 1 | 2015 | 34 | 0.130 |
Why?
| | Hysterectomy | 1 | 2016 | 106 | 0.130 |
Why?
| | Thrombin | 1 | 2016 | 139 | 0.120 |
Why?
| | Reactive Oxygen Species | 2 | 2008 | 531 | 0.120 |
Why?
| | Drug Users | 1 | 2015 | 41 | 0.120 |
Why?
| | Cellulitis | 1 | 2014 | 45 | 0.120 |
Why?
| | Mice | 7 | 2023 | 14860 | 0.120 |
Why?
| | Substance Abuse, Intravenous | 1 | 2015 | 99 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2016 | 478 | 0.100 |
Why?
| | Mice, Knockout | 3 | 2008 | 2565 | 0.100 |
Why?
| | Aged | 6 | 2023 | 19061 | 0.090 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2008 | 157 | 0.090 |
Why?
| | NADPH Oxidases | 2 | 2008 | 120 | 0.090 |
Why?
| | Enterotoxins | 1 | 1990 | 88 | 0.090 |
Why?
| | Animals | 8 | 2023 | 31694 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 1879 | 0.080 |
Why?
| | Pseudomonas aeruginosa | 1 | 2011 | 298 | 0.080 |
Why?
| | Shock, Septic | 1 | 1990 | 186 | 0.080 |
Why?
| | Mice, Inbred C57BL | 2 | 2007 | 4689 | 0.080 |
Why?
| | NADPH Dehydrogenase | 1 | 2008 | 8 | 0.080 |
Why?
| | Respiratory Burst | 1 | 2008 | 28 | 0.080 |
Why?
| | Flavoproteins | 1 | 2007 | 7 | 0.080 |
Why?
| | Hemeproteins | 1 | 2007 | 6 | 0.070 |
Why?
| | Peroxiredoxins | 1 | 2008 | 23 | 0.070 |
Why?
| | Salmonella Infections, Animal | 1 | 2008 | 36 | 0.070 |
Why?
| | Succinate Dehydrogenase | 1 | 2007 | 42 | 0.070 |
Why?
| | Gangliosides | 1 | 2007 | 18 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2008 | 93 | 0.070 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 271 | 0.070 |
Why?
| | Phagocytes | 1 | 2007 | 90 | 0.070 |
Why?
| | Gastric Mucosa | 1 | 2007 | 46 | 0.070 |
Why?
| | Sphingolipids | 1 | 2007 | 57 | 0.070 |
Why?
| | Cytosol | 1 | 2007 | 208 | 0.070 |
Why?
| | Cross Infection | 1 | 2009 | 197 | 0.070 |
Why?
| | Ceramides | 1 | 2007 | 91 | 0.070 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 900 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1177 | 0.070 |
Why?
| | Risk Factors | 5 | 2018 | 8628 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2005 | 256 | 0.060 |
Why?
| | Microscopy, Electron | 1 | 2005 | 410 | 0.060 |
Why?
| | Immunologic Memory | 1 | 2007 | 313 | 0.060 |
Why?
| | RNA, Bacterial | 1 | 2005 | 174 | 0.060 |
Why?
| | Retrospective Studies | 6 | 2018 | 12542 | 0.060 |
Why?
| | Cathelicidins | 1 | 2023 | 38 | 0.060 |
Why?
| | Heparitin Sulfate | 1 | 2023 | 39 | 0.060 |
Why?
| | Oligosaccharides | 1 | 2023 | 46 | 0.060 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 396 | 0.060 |
Why?
| | Humans | 11 | 2023 | 114623 | 0.050 |
Why?
| | Female | 7 | 2018 | 59466 | 0.050 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2023 | 75 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 993 | 0.050 |
Why?
| | Transcription Factors | 1 | 2010 | 1528 | 0.050 |
Why?
| | Virulence | 1 | 2023 | 227 | 0.050 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2007 | 687 | 0.050 |
Why?
| | Middle Aged | 6 | 2018 | 26719 | 0.050 |
Why?
| | Oxidative Stress | 1 | 2008 | 1076 | 0.050 |
Why?
| | Community-Acquired Infections | 2 | 2015 | 141 | 0.050 |
Why?
| | Adult | 6 | 2018 | 30528 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2018 | 3003 | 0.040 |
Why?
| | Hyponatremia | 1 | 2018 | 37 | 0.040 |
Why?
| | Bacteria | 1 | 2023 | 725 | 0.030 |
Why?
| | Colorado | 2 | 2016 | 4099 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 19 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2016 | 111 | 0.030 |
Why?
| | Hospitals, University | 1 | 2016 | 172 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2016 | 6344 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2018 | 410 | 0.030 |
Why?
| | Health Facilities | 1 | 2015 | 72 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 155 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2016 | 195 | 0.030 |
Why?
| | Hearing Loss | 1 | 2018 | 183 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 146 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 497 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2023 | 3531 | 0.030 |
Why?
| | Wound Infection | 1 | 2014 | 30 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1430 | 0.030 |
Why?
| | Male | 5 | 2018 | 55554 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1618 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1796 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1840 | 0.030 |
Why?
| | Cohort Studies | 2 | 2014 | 4894 | 0.030 |
Why?
| | Prevalence | 1 | 2018 | 2249 | 0.020 |
Why?
| | Lung Diseases | 1 | 2018 | 701 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2015 | 490 | 0.020 |
Why?
| | Young Adult | 2 | 2016 | 10455 | 0.020 |
Why?
| | Culture Media | 1 | 1990 | 155 | 0.020 |
Why?
| | Hypertension | 1 | 2018 | 1056 | 0.020 |
Why?
| | Immunity | 1 | 2010 | 121 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2311 | 0.020 |
Why?
| | Rabbits | 1 | 1990 | 733 | 0.020 |
Why?
| | Molecular Epidemiology | 1 | 2009 | 62 | 0.020 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 11 | 0.020 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2008 | 18 | 0.020 |
Why?
| | NADPH Oxidase 2 | 1 | 2008 | 42 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1394 | 0.020 |
Why?
| | Drug Resistance, Microbial | 1 | 2008 | 66 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2010 | 295 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2009 | 311 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 923 | 0.020 |
Why?
| | Organ Specificity | 1 | 2007 | 268 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 430 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2016 | 2128 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2015 | 1815 | 0.010 |
Why?
| | United States | 1 | 2018 | 12176 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 17831 | 0.010 |
Why?
|
|
McCollister's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|